Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 16,394 shares of the company’s stock, valued at approximately $2,117,000.
Other institutional investors have also recently bought and sold shares of the company. Bank of America Corp DE acquired a new stake in Merck KGaA during the 2nd quarter worth about $3,923,774,000. Legal & General Group Plc acquired a new position in shares of Merck KGaA in the second quarter worth about $2,425,225,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in shares of Merck KGaA in the second quarter worth about $942,087,000. Caisse de depot et placement du Quebec purchased a new position in shares of Merck KGaA in the second quarter worth approximately $571,582,000. Finally, Canada Pension Plan Investment Board acquired a new stake in shares of Merck KGaA during the second quarter valued at approximately $536,694,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 3.8%
MKGAF stock opened at $164.12 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market capitalization of $21.21 billion, a P/E ratio of 25.06 and a beta of 0.96. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company’s 50 day simple moving average is $163.35 and its 200-day simple moving average is $149.06.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
